Explore

Trendline Trendline
Alexandria Real Estate Equities to Announce Q2 2026 Financial Results in August

Alexandria Real Estate Equities to Announce Q2 2026 Financial Results in August

Alexandria Real Estate Equities to Announce Q2 2026 Financial Results in August
Trendline Trendline
Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Leukemia Treatment

Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Leukemia Treatment

Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Leukemia Treatment
Trendline Trendline
Ironwood Pharmaceuticals to Present at Jefferies Global Healthcare Conference 2026

Ironwood Pharmaceuticals to Present at Jefferies Global Healthcare Conference 2026

Ironwood Pharmaceuticals to Present at Jefferies Global Healthcare Conference 2026
Trendline Trendline
PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member

PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member

PanTher Therapeutics Advances Pancreatic Cancer Treatment with PTM-101, Appoints New Board Member
Trendline Trendline
Antengene Receives Approval for Phase III Study of ATG-022 in Advanced Gastric Cancer

Antengene Receives Approval for Phase III Study of ATG-022 in Advanced Gastric Cancer

Antengene Receives Approval for Phase III Study of ATG-022 in Advanced Gastric Cancer
Trendline Trendline
InduPro Therapeutics Appoints Dr. Amanda J. Redig as Chief Medical Officer to Advance Oncology Programs

InduPro Therapeutics Appoints Dr. Amanda J. Redig as Chief Medical Officer to Advance Oncology Programs

InduPro Therapeutics Appoints Dr. Amanda J. Redig as Chief Medical Officer to Advance Oncology Programs
Trendline Trendline
Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 Targeting Chronic Myelomonocytic Leukemia

Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 Targeting Chronic Myelomonocytic Leukemia

Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 Targeting Chronic Myelomonocytic Leukemia
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility
Trendline Trendline
MedTherapy Expands CAR-T Manufacturing with New Facility in India

MedTherapy Expands CAR-T Manufacturing with New Facility in India

MedTherapy Expands CAR-T Manufacturing with New Facility in India
Trendline Trendline
Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment

Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment

Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment
Trendline Trendline
D Pharmatech Reports Positive Results for Zabopegdutide in MASH Treatment

D Pharmatech Reports Positive Results for Zabopegdutide in MASH Treatment

D Pharmatech Reports Positive Results for Zabopegdutide in MASH Treatment